A rare and lethal strain of Ebola is tearing through northeastern Democratic Republic of the Congo, killing at least 134 people and infecting nearly 250 more in an outbreak that went undetected for weeks before laboratory tests finally confirmed the virus on May 15, 2026.
The World Health Organization has declared the crisis a public health emergency of international concern — its highest level of alarm — citing the speed of transmission, the conflict-torn terrain where the virus is spreading and the unsettling fact that the species behind the outbreak has no approved vaccine or treatment.
Scientists at the National Institute of Biomedical Research in Kinshasa confirmed Ebola Bundibugyo in eight of 13 samples drawn from a cluster of severe illness and deaths in the Mongbwalu and Rwampara health zones of Ituri Province. So far, 80 community deaths are suspected to be linked to the virus, with the broader case toll continuing to climb.
A Rare Strain With Few Defenses
Bundibugyo is one of three species of Ebola known to cause human outbreaks, but it remains poorly understood. It was first identified in 2007 in the Bundibugyo district of western Uganda, where it sickened 131 people and killed 42 — a case fatality rate of 32%. It surfaced again in 2012, and then went quiet. In both prior outbreaks, it killed roughly 30% of those infected.
That rarity is part of what makes the current outbreak so dangerous. Unlike the more familiar Zaire strain, Bundibugyo has no licensed vaccines or therapeutics — only experimental options. Diagnostic tests also struggle to detect it; initial samples from this outbreak came back negative for Ebola, and it took more sophisticated laboratory work to identify Bundibugyo as the culprit.
Dealing with Bundibugyo is “one of the most significant concerns” in this outbreak, said Professor Trudie Lang of the University of Oxford.
Weeks of Silent Spread
The first known patient was a nurse who developed symptoms on April 24. It then took three weeks for health authorities to confirm an outbreak was underway — a critical lag in a disease that can incubate for as long as 21 days before symptoms emerge. Patients have presented with fever, generalized body pain, weakness, vomiting and, in some cases, bleeding, with several deteriorating rapidly before death.
Dr. Anne Cori of Imperial College London warned that the outbreak has been spreading for weeks undetected, a pattern that complicates efforts to trace contacts and isolate the sick. The affected region presents a punishing operational landscape: urban centers churning with population movements tied to mining, persistent insecurity from a long-running civil war, and more than 250,000 people displaced from their homes. Frequent cross-border traffic further raises the risk of transmission.
The virus has already slipped beyond Congo’s borders. In neighboring Uganda, health authorities confirmed Bundibugyo in a patient who had traveled from the DRC and later died at a health facility. A second case has since been identified there. Uganda, South Sudan and Rwanda are all considered high risk because of dense trade and travel links with the affected provinces.
A Familiar Country, an Unfamiliar Enemy
This marks the 17th recorded Ebola outbreak in the DRC since the virus was first identified in 1976 in Yambuku, in Equateur Province. The last outbreak ended only in December 2025. That long history has built deep institutional muscle memory — but it has not equipped the country to confront this particular strain.
“The Democratic Republic of the Congo has extensive experience responding to Ebola outbreaks, and WHO is rapidly scaling up support to the ongoing response,” said Dr. Mohamed Janabi, the WHO Regional Director for Africa.
The agency is airlifting five metric tons of supplies — infection control gear, laboratory transport equipment, case management materials and tents — from Kinshasa to Bunia to bolster frontline health workers. Additional epidemiologists, clinicians and logistics specialists are being deployed to reinforce surveillance, contact tracing and safe burials.
Global Risk Remains Low
An international emergency declaration does not imply a COVID-style pandemic threat. Ebola spreads through direct contact with infected bodily fluids, and transmission typically does not occur until symptoms appear. Even during the catastrophic 2014-16 outbreak that infected 28,600 people across West Africa, the United Kingdom recorded just three cases — all healthcare workers who had volunteered overseas.
The risk Ebola poses to the wider world remains tiny, but the WHO designation signals something else. “It does reflect that the situation is complex enough to require international coordination,” Dr. Amanda Rojek, of the Pandemic Sciences Institute at the University of Oxford, told reporters.
Without a vaccine or targeted drug, treatment for Bundibugyo relies on optimized supportive care — managing pain, secondary infections, fluids and nutrition. Early intervention improves survival, but in a region torn by war and displacement, reaching the sick in time is the hardest battle of all. Symptoms can begin like the flu: fever, headache and fatigue. Then come the vomiting, diarrhea, organ failure and, for some, internal and external bleeding. About a third of patients die.
